Nexien Biopharma Stock Analysis
NXEN Stock | USD 0.01 0.01 30.00% |
Nexien Biopharma is fairly valued with Real Value of 0.0134 and Hype Value of 0.01. The main objective of Nexien Biopharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Nexien Biopharma is worth, separate from its market price. There are two main types of Nexien Biopharma's stock analysis: fundamental analysis and technical analysis.
The Nexien Biopharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Nexien |
Nexien Pink Sheet Analysis Notes
About 54.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Nexien Biopharma last dividend was issued on the 29th of November 2017. The entity had 1:6 split on the 29th of November 2017. Nexien BioPharma, Inc. operates as a pharmaceutical company. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Nexien Biopharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Nexien Biopharma contact Richard Greenberg at 303 495 7583 or learn more at https://www.nexienbiopharma.com.Nexien Biopharma Investment Alerts
Nexien Biopharma is way too risky over 90 days horizon | |
Nexien Biopharma has some characteristics of a very speculative penny stock | |
Nexien Biopharma appears to be risky and price may revert if volatility continues | |
Nexien Biopharma has high likelihood to experience some financial distress in the next 2 years | |
Nexien Biopharma currently holds 221.73 K in liabilities with Debt to Equity (D/E) ratio of 0.36, which is about average as compared to similar companies. Nexien Biopharma has a current ratio of 0.5, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nexien Biopharma until it has trouble settling it off, either with new capital or with free cash flow. So, Nexien Biopharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nexien Biopharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nexien to invest in growth at high rates of return. When we think about Nexien Biopharma's use of debt, we should always consider it together with cash and equity. | |
Net Loss for the year was (626.36 K) with profit before overhead, payroll, taxes, and interest of 0. | |
Nexien Biopharma currently holds about 116.9 K in cash with (75.14 K) of positive cash flow from operations. | |
Roughly 54.0% of Nexien Biopharma outstanding shares are owned by corporate insiders |
Nexien Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nexien Biopharma's market, we take the total number of its shares issued and multiply it by Nexien Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 5th of December, Nexien Biopharma secures the Downside Deviation of 38.08, risk adjusted performance of 0.1068, and Mean Deviation of 19.95. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nexien Biopharma, as well as the relationship between them.Nexien Biopharma Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nexien Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nexien Biopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Nexien Biopharma Outstanding Bonds
Nexien Biopharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nexien Biopharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nexien bonds can be classified according to their maturity, which is the date when Nexien Biopharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
NextEra Energy Operating Corp BondUS65342QAB86 | View | |
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
NextEra Energy Operating Corp BondUS65342QAL68 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View |
Nexien Biopharma Predictive Daily Indicators
Nexien Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nexien Biopharma pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daily Balance Of Power | (9,223,372,036,855) | |||
Rate Of Daily Change | 0.7 | |||
Day Median Price | 0.014 | |||
Day Typical Price | 0.014 | |||
Price Action Indicator | (0) | |||
Period Momentum Indicator | (0.01) |
Nexien Biopharma Forecast Models
Nexien Biopharma's time-series forecasting models are one of many Nexien Biopharma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nexien Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Nexien Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Nexien Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nexien shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Nexien Biopharma. By using and applying Nexien Pink Sheet analysis, traders can create a robust methodology for identifying Nexien entry and exit points for their positions.
Nexien BioPharma, Inc. operates as a pharmaceutical company. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Nexien Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
All Next | Launch Module |
Other Information on Investing in Nexien Pink Sheet
Nexien Biopharma financial ratios help investors to determine whether Nexien Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nexien with respect to the benefits of owning Nexien Biopharma security.